Example: Heart Attack

Search clinical trials for: MK0683, vorinostat, Suberoylanilide Hydroxamic Acid (SAHA) / Duration of Treatment 6 Months

Total 3 results

NCT00109109

Terminated

A Clinical Trial of Oral Suberoylanilide Hydroxamic Acid (SAHA) in Patients With Advanced Multiple Myeloma (0683-004)

Conditions: Multiple Myeloma
NCT00097929

Completed

An Investigational Drug Study With Suberoylanilide Hydroxamic Acid in Relapsed Diffuse Large B-cell Lymphoma (0683-013)

Conditions: B-cell Lymphoma
NCT00091559

Completed

Oral SAHA (Suberoylanilide Hydroxamic Acid) in Advanced Cutaneous T-cell Lymphoma (0683-001)

Conditions: Cutaneous T-cell Lymphoma, Sezary Syndrome, Mycosis Fungoides